Neoveil® Versus TachoSil® for the Treatment of Pulmonary Air Leaks Following Lung Operation

Postoperative Air Leak Clinical Trial

Official title:
Neoveil® Versus TachoSil® for the Treatment of Pulmonary Air Leaks Following Lung Operation

Status Completed

Clinical Trial Summary

Postoperative prolonged air leak (PAL), referring to the passage of air from the lung parenchyma into the pleural space, is one of the most frequent postoperative complications after lung resection. To control air leak, there are two different products certified since years: TachoSil® and Neoveil®. This study is to investigate the difference of TachoSil® and Neoveil® in patients with PAL.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04065880
Study type	Interventional
Source	University Hospital, Basel, Switzerland
Contact
Status	Completed
Phase	N/A
Start date	April 1, 2020
Completion date	July 31, 2021

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT03943511` - Discharged With Indwelling Chest Tube and Valve	N/A
Completed	`NCT02491671` - Effectiveness Novel Tissue Sealant, Prevention Prolonged Air Leak (PAL) After Lung Resection	Phase 3
Active, not recruiting	`NCT06356038` - Phrenic Nerve Infiltration: Pulmonary Expansion and Pain Control	N/A
Completed	`NCT01166516` - IBV Valve System for the Treatment of Prolonged Air Leak Under HDE H060002 - Post Approval Study	N/A